Cellectar Corp - Utang jangka cendhak perusahaan CLRB

Cellectar Biosciences (CLRB) attracts rare radiochemists through premium bonuses and scientific prestige. The company's short-term debt dynamics illustrate working capital management, where the value of 0.00 expresses the metric level. Efficient isotope aviation logistics support the business, although the expansion of pharma behemoths into radiopharmaceuticals intensifies the struggle for patents and specialized laboratories.

CLRB (Cellectar Biosciences, Inc.) riwayat Utang jangka cendhak perusahaan saka 04.07.2022 nganti 28.10.2026

Cellectar Corp - rincian analitis lan metrik utama (CLRB)

- rega lan prakiraan konsensus rega:

Rega saham Cellectar Biosciences, Inc.|CLRB - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Cellectar Biosciences, Inc.|CLRB - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Nilai Buku saben Saham Cellectar Biosciences|CLRB - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku cellectar.com|CLRB - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Total Utang marang Ekuitas Cellectar Biosciences|CLRB - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Cellectar Biosciences|CLRB - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Cellectar Biosciences, Inc.|CLRB - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Cellectar Biosciences

Pambiji fundamental perusahaan:Cellectar Biosciences

Portfolio managers are evaluating the operating model of Cellectar Biosciences (CLRB) through the lens of short-term liquidity, where this metric measures the speed of meeting current obligations and the inertia of the credit load. An analysis of short-term liabilities confirms the financial stability of the radiopharmaceutical aviation logistics, ensuring that the express delivery of isotopes is supported by stable capital without the need for emergency asset sales to cover debts.

Pesaing Cellectar Biosciences (CLRB)